Loomis, Sayles & Company’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7K Buy
161
+63
+64% +$11.1K ﹤0.01% 681
2026
Q1
$17.6K Buy
+98
New +$16.7K ﹤0.01% 687
2024
Q1
Sell
-123
Closed -$18K 702
2023
Q4
$18K Buy
123
+74
+151% +$10.2K ﹤0.01% 691
2023
Q3
$8K Buy
49
+25
+104% +$4.98K ﹤0.01% 827
2023
Q2
$5K Sell
24
-1,392
-98% -$285K ﹤0.01% 822
2023
Q1
$313K Buy
1,416
+48
+4% +$11.8K ﹤0.01% 494
2022
Q4
$297K Hold
1,368
﹤0.01% 483
2022
Q3
$362K Sell
1,368
-102
-7% -$25.9K ﹤0.01% 439
2022
Q2
$307K Buy
+1,470
New +$328K ﹤0.01% 473
2021
Q2
Sell
-92
Closed -$13K 830
2021
Q1
$13K Buy
+92
New +$14.8K ﹤0.01% 715

Other funds holding ALB

Loomis, Sayles & Company's ALB Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Albemarle (ALB) stake by 64% in Q2 2026, buying an estimated $11.1K and bringing the position to 161 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #681.

Loomis, Sayles & Company first reported a position in ALB in Q1 2021 and has held it in 10 quarters since. The position peaked at $362K in Q3 2022. 943 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Loomis, Sayles & Company held 161 shares of Albemarle worth $21.7K as of Q2 2026.
  • Loomis, Sayles & Company bought 63 Albemarle shares in Q2 2026, an estimated $11.1K.
  • Albemarle made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #681 holding.
  • Loomis, Sayles & Company first reported a position in Albemarle in Q1 2021 and has held it in 10 quarters since.
  • Loomis, Sayles & Company's Albemarle position peaked at $362K in Q3 2022.
  • 943 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.